Joseph Edelman's Net Worth

$715 Million

Who is Joseph Edelman?

Joseph Edelman has an estimated net worth of $715 Million. This is based on reported shares across multiple companies, which include CARGO Therapeutics, Inc., VBI VACCINES INC., ZOGENIX, INC., Prometheus Biosciences, Inc., BIOSANTE PHARMACEUTICALS INC, Crinetics Pharmaceuticals, Inc., ALBIREO PHARMA, INC., Nautilus Biotechnology, Inc., Aldeyra Therapeutics, Inc., ANTARES PHARMA INC, Athira Pharma, Inc., Verrica Pharmaceuticals Inc., LianBio, MeiraGTx Holdings plc, ARYA Sciences Acquisition Corp IV, ARYA Sciences Acquisition Corp V, ADMA BIOLOGICS, INC., AMICUS THERAPEUTICS, INC., Global Blood Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., Kadmon Holdings, Inc., Menlo Therapeutics Inc., AGILE THERAPEUTICS INC, Solid Biosciences Inc., IsoPlexis Corp, XTL BIOPHARMACEUTICALS LTD, Lyra Therapeutics, Inc., Landos Biopharma, Inc., Motus GI Holdings, Inc., VBI Vaccines Inc/BC, Corium International, Inc., Astria Therapeutics, Inc., SCYNEXIS INC, LEAP THERAPEUTICS, INC., Rain Therapeutics Inc., Quotient Ltd, Athenex, Inc., LA JOLLA PHARMACEUTICAL CO, Versartis, Inc., ACELRX PHARMACEUTICALS INC, Dova Pharmaceuticals Inc., CHEMBIO DIAGNOSTICS, INC., SOLENO THERAPEUTICS INC, REPROS THERAPEUTICS INC., SYNAGEVA BIOPHARMA CORP, Acrivon Therapeutics, Inc., OPTIMER PHARMACEUTICALS INC, ARYA SCIENCES ACQUISITION CORP., Aegerion Pharmaceuticals, Inc., Foamix Pharmaceuticals Ltd., MIRAVANT MEDICAL TECHNOLOGIES, INDEVUS PHARMACEUTICALS INC, BIOENVISION INC, MACROCHEM CORP, PENWEST PHARMACEUTICALS CO, PALATIN TECHNOLOGIES INC, and CYPRESS BIOSCIENCE INC.

SEC CIK

Joseph Edelman's CIK is 0001164426

Past Insider Trading and Trends

2008 was Joseph Edelman's most active year for acquiring shares with 200 total transactions. Joseph Edelman's most active month to acquire stocks was the month of December. 2021 was Joseph Edelman's most active year for disposing of shares, totalling 47 transactions. Joseph Edelman's most active month to dispose stocks was the month of December. 2022 saw Joseph Edelman paying a total of $222,247,925.28 for 18,920,433 shares, this is the most they've acquired in one year. In 2018 Joseph Edelman cashed out on 22,997,352 shares for a total of $45,549,851.06, their largest year based on trade value.